EMAIL THIS PAGE TO A FRIEND

PLoS pathogens

E3 Ubiquitin Ligase NEDD4 Promotes Influenza Virus Infection by Decreasing Levels of the Antiviral Protein IFITM3.


PMID 26263374

Abstract

Interferon (IFN)-induced transmembrane protein 3 (IFITM3) is a cell-intrinsic factor that limits influenza virus infections. We previously showed that IFITM3 degradation is increased by its ubiquitination, though the ubiquitin ligase responsible for this modification remained elusive. Here, we demonstrate that the E3 ubiquitin ligase NEDD4 ubiquitinates IFITM3 in cells and in vitro. This IFITM3 ubiquitination is dependent upon the presence of a PPxY motif within IFITM3 and the WW domain-containing region of NEDD4. In NEDD4 knockout mouse embryonic fibroblasts, we observed defective IFITM3 ubiquitination and accumulation of high levels of basal IFITM3 as compared to wild type cells. Heightened IFITM3 levels significantly protected NEDD4 knockout cells from infection by influenza A and B viruses. Similarly, knockdown of NEDD4 in human lung cells resulted in an increase in steady state IFITM3 and a decrease in influenza virus infection, demonstrating a conservation of this NEDD4-dependent IFITM3 regulatory mechanism in mouse and human cells. Consistent with the known association of NEDD4 with lysosomes, we demonstrate for the first time that steady state turnover of IFITM3 occurs through the lysosomal degradation pathway. Overall, this work identifies the enzyme NEDD4 as a new therapeutic target for the prevention of influenza virus infections, and introduces a new paradigm for up-regulating cellular levels of IFITM3 independently of IFN or infection.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

07-049
Anti-Nedd4 Antibody, WW2 domain, 200 µL, Detect Nedd4 using this Anti-Nedd4 Antibody, WW2 domain validated for use in IH & WB.
GW21184P Anti-c-Myc (ab1) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW21222 Anti-c-Myc (ab2) antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4300319
Anti-MYC (Ab-358) antibody produced in rabbit, affinity isolated antibody
SAB4300320
Anti-MYC (Ab-373) antibody produced in rabbit, affinity isolated antibody
SAB4300318
Anti-MYC (Ab-58) antibody produced in rabbit, affinity isolated antibody
SAB2103448
Anti-MYC, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4501941
Anti-MYC, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4503661
Anti-MYC, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4503662
Anti-MYC, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2101562
Anti-NEDD4 antibody produced in rabbit, affinity isolated antibody
HPA039883
Anti-NEDD4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1307231
ANTI-NEDD4(C-TERMINAL) antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
CKOZFN10472 CompoZr® Knockout ZFN Kit, Human IFITM3 (NM_021034)
12-349
Goat Anti-Mouse IgG Antibody, HRP conjugate, 500 µg, Goat Anti-Mouse IgG Antibody, HRP conjugate is an antibody against Mouse IgG for use in ELISA, IH & WB.
EHU222801 MISSION® esiRNA, esiRNA targeting human IFITM3
EMU207441 MISSION® esiRNA, esiRNA targeting mouse Ifitm3
SAB3300002
Monoclonal Anti-c-Myc antibody produced in mouse, clone 1A6, purified immunoglobulin, buffered aqueous glycerol solution
SAB4700447 Monoclonal Anti-MYC , (C-terminal) antibody produced in mouse, clone 9E10, purified immunoglobulin, buffered aqueous solution
WH0004609M2
Monoclonal Anti-MYC antibody produced in mouse, clone 1G7, purified immunoglobulin, buffered aqueous solution
SRP0226
NEDD4 Active human, recombinant, expressed in baculovirus infected insect cells, ≥60% (SDS-PAGE)
PLA0001
Rabbit anti-c-myc Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
ARK2174
Triethanolamine, PharmaGrade, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C6H15NO3
90278
Triethanolamine, BioUltra, ≥99.5% (GC)
C6H15NO3
90279
Triethanolamine, ≥99.0% (GC)
C6H15NO3
33729
Triethanolamine, puriss. p.a., ≥99% (GC)
C6H15NO3
T58300
Triethanolamine, reagent grade, 98%
C6H15NO3